Laidlaw Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Laidlaw Wealth Management's AMGN Position: Q1 2025 in Review
Laidlaw Wealth Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 2,288 shares — an estimated $596K sold.
Laidlaw Wealth Management first reported a position in AMGN in Q4 2019 and held it in 19 quarters. The position peaked at $2.65M in Q4 2022. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Laidlaw Wealth Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
- Laidlaw Wealth Management sold 2,288 Amgen shares in Q1 2025, an estimated $596K.
- Laidlaw Wealth Management first reported a position in Amgen in Q4 2019 and held it in 19 quarters.
- Laidlaw Wealth Management's Amgen position peaked at $2.65M in Q4 2022.
- 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Laidlaw Wealth Management's 13F filing for Q1 2025, filed 16 May 2025.